Efficacy of Neoadjuvant Therapy with Trastuzumab Concurrent with Anthracycline- and Non-anthracycline-based Regimens for HER2-Positive Breast Cancer

BACKGROUND: To evaluate the pathologic complete response (pCR) rates and relapse-free survival (RFS) and overall survival (OS) of patients receiving neoadjuvant systemic therapy (NST) with trastuzumab in combination with an anthracycline- or a non-anthracycline-based regimen. METHODS: In this retros...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bayraktar, Soley, Gonzalez-Angulo, Ana M., Lei, Xiudong, Buzdar, Aman U., Valero, Vicente, Melhem-Bertrandt, Amal, Kuerer, Henry M., Hortobagyi, Gabriel N., Sahin, Aysegul A., Meric-Bernstam, Funda
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3274632/
https://ncbi.nlm.nih.gov/pubmed/21953213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26555
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires